Details of the Drug Formulations

General Information of Drug (ID: DM1CI9R)

• Drug Name: Bempedoic acid Drug Info
• Synonyms: ETC-1002; bempedoic acid; 738606-46-7; 8-Hydroxy-2,2,14,14-tetramethylpentadecanedioic acid; ESP-55016; UNII-1EJ6Z6Q368; ETC 1002; Bempedoic acid; ESP-55016; 1EJ6Z6Q368; Bempedoate; Bempedoic acid [USAN:INN]; ETC1002; ESP 55016; Bempedoic acid (USAN/INN); SCHEMBL185768; GTPL8321; CHEMBL3545313; HYHMLYSLQUKXKP-UHFFFAOYSA-N; EX-A1243; ZINC3948738; BCP16083; s7953; AKOS027439916; CS-3952; DB11936; AK499358; AC-29040; AS-49804; HY-12357; Bempedoic Acid(ETC-1002;ESP-55016); D10691; Pentadecanedioic acid, 8-hydroxy-2,2,14,14-tetramethyl-

Indication

Disease Entry	ICD 11	Status	REF
Familial hypercholesterolemia	5C80.00	Approved	[1]
Cardiovascular disease	BA00-BE2Z	Phase 3	[2]

• Cross-matching ID:
  PubChem CID: 10472693
  ChEBI ID: CHEBI:149601
  CAS Number: 738606-46-7
  TTD ID: D0D9NY
  ACDINA ID: D00867

Full List of Drug Formulations Containing This Drug

Bempedoic Acid 180mg tablet

Company	Formulation ID	FDA Description
Esperion Theraps	F23082	Colloidal Silicon Dioxide; Hydroxyl Propyl Cellulose; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Sodium Starch Glycolate; Partially Hydrolyzed Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)